FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 300:1001-1005 May 3, 1979 Number 18 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To determine whether sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency influence the course and fatality rates of certain diseases requiring hospitalization, especially those associated with thrombotic phenomena, we conducted a co-operative study of 65,154 consecutively admitted, black male patients in 13 Veterans Administration hospitals. The overall frequency of sickle-cell trait was 7.8 per cent and of glucose-6-phosphate dehydrogenase dificiency 11.2 per cent. Both conditions were present in 0.9 per cent of those examined. There were regional, but no age-dependent, differences in the frequency of sickle-cell trait. Sickle-cell trait had no effect on average age at hospitalization or death, overall mortality, length of hospitalization on medical and surgical wards and frequency of any diagnosis, except essential hematuria and pulmonary embolism. Although statistically significant (P less than 0.001), the differences for the latter were small (1.5 per cent of all patients with normal hemoglobin and 2.2 per cent of patients with sickle-cell trait). Glucose-6-phosphate dehydrogenase deficiency had no adverse effect.

This article has been cited by other articles:

• Al-Ebrahim, K. E (2008). Cardiac Surgery and Sickle Cell Disease. Asian Cardiovasc. Thorac. Ann. 16: 479-482 [Abstract] [Full Text]  
• Tungsiripat, M., Drechsler, H., Sarlone, C., Amyot, K., Laffey, E., Aberg, J. (2008). Prevalence and Significance of G6PD Deficiency in Patients of an Urban HIV Clinic. J Int Assoc Physicians AIDS Care (Chic Ill) 7: 88-90 [Abstract]  
• Austin, H., Key, N. S., Benson, J. M., Lally, C., Dowling, N. F., Whitsett, C., Hooper, W. C. (2007). Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 110: 908-912 [Abstract] [Full Text]  
• Dowling, M. M. (2005). Sickle Cell Trait Is Not a Risk Factor for Stroke. Arch Neurol 62: 1780-1781 [Full Text]  
• Kaplan, M., Herschel, M., Hammerman, C., Hoyer, J. D., Stevenson, D. K. (2004). Hyperbilirubinemia Among African American, Glucose-6-Phosphate Dehydrogenase-Deficient Neonates. Pediatrics 114: e213-e219 [Abstract] [Full Text]  
• Shechter, I., Dai, P., Huo, L., Guan, G. (2003). IDH1 gene transcription is sterol regulated and activated by SREBP-1a and SREBP-2 in human hepatoma HepG2 cells: evidence that IDH1 may regulate lipogenesis in hepatic cells. J. Lipid Res. 44: 2169-2180 [Abstract] [Full Text]  
• Steen, R. G., Hankins, G. M., Xiong, X., Wang, W. C., Beil, K., Langston, J. W., Helton, K. J. (2003). Prospective Brain Imaging Evaluation of Children with Sickle Cell Trait: Initial Observations. Radiology 228: 208-215 [Abstract] [Full Text]  
• Kaplan, M., Hammerman, C. (2000). Glucose-6-Phosphate Dehydrogenase-Deficient Neonates: A Potential Cause for Concern in North America. Pediatrics 106: 1478-1479 [Full Text]  
• Steinberg, M. H. (1999). Management of Sickle Cell Disease. NEJM 340: 1021-1030 [Full Text]